|
Market Closed -
Nasdaq Stockholm
04:00:00 18/11/26 am AEDT
|
5-day change | 1st Jan Change | ||
| 547.00 SEK | -2.06% |
|
-1.35% | -0.36% |
| 07/11 | PriorNilsson Evolve Global fell 3.93% in October, industrial stocks weighed | FW |
| 03/11 | Linc's net asset value rose to SEK 80.80 per share in October | FW |
Company Valuation: MedCap AB
Data adjusted to current consolidation scope
| Fiscal Period: December | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|
| Market Cap 1 | 4,997 | 8,899 | 8,278 | 8,192 | - | - |
| Change | - | 78.07% | -6.99% | -1.04% | - | - |
| Enterprise Value (EV) 1 | 4,997 | 9,176 | 8,359 | 8,361 | 8,141 | 7,921 |
| Change | - | 83.61% | -8.9% | 0.02% | -2.63% | -2.7% |
| P/E | 29.1x | 42.9x | - | 29x | 26.9x | 23.9x |
| PBR | - | 6.95x | - | 4.6x | 3.92x | 3.37x |
| PEG | - | 2.1x | - | - | 3.53x | 1.9x |
| Capitalization / Revenue | - | 4.93x | 3.93x | 3.45x | 3.13x | 2.87x |
| EV / Revenue | - | 5.08x | 3.97x | 3.52x | 3.11x | 2.78x |
| EV / EBITDA | - | 23.7x | 18.3x | 14x | 13.6x | 12x |
| EV / EBIT | - | 33.7x | 27.6x | 20.2x | 19.8x | 17.7x |
| EV / FCF | - | 28.8x | 26.4x | 39.9x | 23.9x | 20.3x |
| FCF Yield | - | 3.47% | 3.79% | 2.51% | 4.19% | 4.94% |
| Dividend per Share 2 | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - |
| EPS 2 | 11.6 | 14 | - | 18.88 | 20.32 | 22.91 |
| Distribution rate | - | - | - | - | - | - |
| Net sales 1 | - | 1,807 | 2,108 | 2,376 | 2,616 | 2,850 |
| EBITDA 1 | - | 387.7 | 456.3 | 598 | 599.5 | 657.5 |
| EBIT 1 | - | 272.3 | 302.9 | 413.5 | 410.5 | 448.5 |
| Net income 1 | 172.2 | 207.4 | 219.8 | 282 | 296.5 | 330 |
| Net Debt 1 | - | 276.5 | 81.3 | 169 | -51 | -271 |
| Reference price 2 | 337.50 | 601.00 | 549.00 | 547.00 | 547.00 | 547.00 |
| Nbr of stocks (in thousands) | 14,807 | 14,807 | 15,078 | 14,976 | - | - |
| Announcement Date | 31/1/24 | 31/1/25 | 5/2/26 | - | - | - |
1SEK in Million2SEK
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| - | 3.59x | 14.27x | - | 829M | ||
| 22.75x | 6.2x | 13.4x | 1.91% | 185B | ||
| 14.25x | 3.39x | - | 2.52% | 146B | ||
| 16.25x | 7.37x | - | 1.52% | 102B | ||
| 19.65x | 7.01x | 12.49x | 4.34% | 93.58B | ||
| 19.07x | 11.31x | 16.83x | 0.82% | 85.17B | ||
| 20.69x | 12.96x | 22.5x | 3.95% | 81.32B | ||
| 15.06x | 11.24x | 8.75x | 1.86% | 70.84B | ||
| 12.65x | 4.83x | - | 2.06% | 46.26B | ||
| Average | 17.54x | 7.54x | 14.71x | 2.37% | 90B | |
| Weighted average by Cap. | 18.20x | 7.51x | 14.60x | 2.35% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- MCAP Stock
- Valuation MedCap AB
Select your edition
All financial news and data tailored to specific country editions
















